|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: LUCAT1 |
Gene summary for LUCAT1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | LUCAT1 | Gene ID | 100505994 |
| Gene name | lung cancer associated transcript 1 | |
| Gene Alias | SCAL1 | |
| Cytomap | 5q14.3 | |
| Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 100505994 | LUCAT1 | HCC1_Meng | Human | Liver | HCC | 6.23e-31 | 1.43e-01 | 0.0246 |
| 100505994 | LUCAT1 | HCC2 | Human | Liver | HCC | 1.25e-18 | 2.21e+00 | 0.5341 |
| 100505994 | LUCAT1 | HCC5 | Human | Liver | HCC | 9.51e-14 | 1.38e+00 | 0.4932 |
| 100505994 | LUCAT1 | S027 | Human | Liver | HCC | 7.33e-06 | 4.00e-01 | 0.2446 |
| 100505994 | LUCAT1 | S028 | Human | Liver | HCC | 1.93e-03 | 2.11e-01 | 0.2503 |
| 100505994 | LUCAT1 | S029 | Human | Liver | HCC | 1.70e-07 | 3.49e-01 | 0.2581 |
| 100505994 | LUCAT1 | RNA-P17T-P17T-2 | Human | Lung | IAC | 6.80e-05 | 7.57e-01 | 0.3371 |
| 100505994 | LUCAT1 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.48e-03 | 5.28e-01 | 0.343 |
| 100505994 | LUCAT1 | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.48e-03 | 6.50e-01 | 0.3385 |
| 100505994 | LUCAT1 | RNA-P17T-P17T-8 | Human | Lung | IAC | 4.12e-03 | 5.80e-01 | 0.3329 |
| 100505994 | LUCAT1 | RNA-P3T-P3T-1 | Human | Lung | IAC | 1.03e-03 | 4.43e-01 | 0.1829 |
| 100505994 | LUCAT1 | RNA-P3T-P3T-2 | Human | Lung | IAC | 1.96e-04 | 4.65e-01 | 0.1835 |
| 100505994 | LUCAT1 | RNA-P3T-P3T-4 | Human | Lung | IAC | 4.11e-06 | 5.21e-01 | 0.1859 |
| 100505994 | LUCAT1 | RNA-P7T1-P7T1-1 | Human | Lung | AIS | 7.48e-05 | 5.73e-01 | -0.0961 |
| 100505994 | LUCAT1 | RNA-P7T1-P7T1-2 | Human | Lung | AIS | 3.45e-03 | 3.93e-01 | -0.0876 |
| 100505994 | LUCAT1 | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 2.91e-02 | 4.07e-01 | -0.0822 |
| 100505994 | LUCAT1 | male-WTA | Human | Thyroid | PTC | 6.51e-04 | 1.21e-02 | 0.1037 |
| 100505994 | LUCAT1 | PTC04 | Human | Thyroid | PTC | 1.03e-08 | 1.44e-01 | 0.1927 |
| 100505994 | LUCAT1 | PTC06 | Human | Thyroid | PTC | 1.14e-06 | 1.59e-01 | 0.2057 |
| 100505994 | LUCAT1 | PTC07 | Human | Thyroid | PTC | 1.34e-07 | 1.06e-01 | 0.2044 |
| Page: 1 2 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Lung |  | AAH: Atypical adenomatous hyperplasia |
| AIS: Adenocarcinoma in situ | ||
| IAC: Invasive lung adenocarcinoma | ||
| MIA: Minimally invasive adenocarcinoma | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |